The Genetic Differences among Colistin-Resistant Enterobacterales, Acinetobacter spp. and Pseudomonas aeruginosa
A special issue of Antibiotics (ISSN 2079-6382). This special issue belongs to the section "Mechanism and Evolution of Antibiotic Resistance".
Deadline for manuscript submissions: closed (31 March 2023) | Viewed by 4306
Special Issue Editors
Interests: antibiotic resistance; carbapenems; carbapenemases; hospital infections; Acinetobacter; Klebsiella; molecular epidemiology; infection control; antibiotic stewardship; medical microbiology
Interests: genotyping; horizontal gene transfer of antimicrobial resistance; MDR Acinetobacter baumannii; MDR Klebsiella pneumoniae; molecular epidemiology of healthcare-associated infections
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Colistin is one of the few remaining antimicrobials able to be used as last resort against severe infections caused by Enterobacterales, Acinetobacter spp. and Pseudomonas aeruginosa. This Special Issue will focus on colistin resistance in Enterobacterales, Acinetobacter spp. and Pseudomonas aeruginosa. The aim is to present original research or review manuscripts dealing with different aspects of colistin resistance: molecular epidemiology and dissemination of colistin-resistant pathogens; molecular mechanisms of resistance and genetic acquisition; diagnostics; antimicrobial regimen–antimicrobial therapy. Particular consideration will be given to transdisciplinary research focused on the development of molecular, cellular, microbiological, computational and epidemiological approaches to addressing pathogen drug resistance. Studies assessing interactions among multi- and pan-drug resistance phenotypes and their genetic basis are encouraged, along with those examining the genomic and evolutionary context of mobilized, amplified or rearranged drug resistance genes. Lastly, papers bridging molecular diagnostics and surveillance of genetic elements associated with drug resistance would be appreciated.
Dr. Spyros Pournaras
Prof. Dr. Raffaele Zarrilli
Prof. Dr. Katy Jeannot
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Antibiotics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
